Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

Stuart E. Starr, Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Richard C. Brundage(MelroseWakefield Healthcare), William D. Fiske, Courtney V. Fletcher(University of Nebraska at Omaha), Stephen A. Spector(University of California San Diego), Bobbie Graham(Frontier Science & Technology Research Foundation, Inc.), Merril Gersten(University of California San Diego), Florence H. Yong(MelroseWakefield Healthcare), Douglas J. Manion(Wilmington University), James McNamara(National Institute of Allergy and Infectious Diseases), Harold W. Lischner, Suzanne Siminski, Lynette Purdue(National Institutes of Health), Wayne M. Dankner(University of California San Diego), Nancy Ruíz(Wilmington University), Carol Vincent(Wake Forest University), Terence Fenton(GTx (United States)), Mark Becker(Agouron Institute), David M. Kornhauser, Patricia M. Flynn(St. Jude Children's Research Hospital)
New England Journal of Medicine
December 16, 1999
Cited by 211


Related Papers